Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nikkol Group is a prominent Japanese specialty chemical organization that focuses on the research, development, and manufacturing of high-performance ingredients for the cosmetics and pharmaceutical sectors. The group is anchored by Nikko Chemicals and is globally recognized for its expertise in colloid chemistry, skin science, and drug delivery systems (DDS). They provide a comprehensive portfolio of pharmaceutical excipients, including high-purity surfactants, oils, and lipids designed to enhance the stability and bioavailability of active ingredients. Beyond raw material supply, Nikkol Group offers formulation support and contract manufacturing services through its specialized subsidiaries. Their innovative technologies in liposomes and nano-emulsions are widely utilized in both topical and systemic drug applications. The company maintains a strong commitment to quality and sustainability, operating multiple GMP-compliant facilities to serve a global client base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nikkol Group.